Introduction
Before 2022, monkeypox virus (Mpox) infection in humans was primarily found in Central and West African regions where the virus is endemic. Human-to-human transmission of Mpox is commonly attributed to respiratory droplets or direct contact with mucocutaneous lesions of an infected individual [1]. Despite the virus being present in endemic regions for many years, research into Mpox has been largely neglected.
However, since May 2022, the World Health Organization declared it an “evolving threat of moderate public health concern” after over 3,000 cases were reported in more than 50 countries across five regions [2].
Anzeige
Since the onset of the Mpox outbreak, and as of 29 March 2023, a total of 86.746 cases have been identified across 45 countries and regions within the European Region [3]. The majority of cases were reported among individuals between the ages of 31 and 40, with a higher prevalence among males. Notably, men who have sex with men (MSM) have been disproportionately affected, suggesting an amplification of transmission through sexual routes. Moreover, among cases with available HIV status information, 38% of the infected individuals were found to be HIV-positive [3].
The increase in the number of monkeypox cases has coincided with a significant surge in the dissemination of misinformation through social media platforms, which are increasingly utilised as health research tools [4]. This misinformation has led to stigmatisation and undermined adherence to public health guidance. To combat the deleterious effects of this “misinfodemic,” it is essential to gauge the population’s perceptions and level of awareness of monkeypox. Stigma during the Mpox pandemic drew parallels with the long-standing discrimination and mistreatment that people with HIV have faced for years. Both epidemics show “othering,” creating stigma that leads to social isolation and mistreatment, limiting access to resources and opportunities, social cohesion, and hinder disease prevention efforts [5]. Stigma can also have negative effects on mental health and may lead to a decline in testing during outbreaks. In the case of Mpox, stigma could discourage individuals from seeking help or getting vaccinated [6].
Limited research has concentrated on understanding the awareness and perceptions of Mpox within the population at higher risk of contracting it. Several surveys have explored Mpox knowledge among healthcare professionals and university students in non-endemic countries. Even in this group, findings indicate a suboptimal level of knowledge [7, 8].
To date, very few studies have investigated the level of awareness and actions taken by the population at risk of contracting the disease and the connection between their behaviour and other important factors, such as level of education and main source of information. Notably, these two factors proved pivotal during the recent SARS-CoV-2 pandemic, especially in terms of acceptance of the regulations and vaccinations.
Anzeige
Identifying and evaluating factors the general knowledge and awareness of Mpox in at-risk population groups is crucial in developing targeted and effective strategies to address this infection.
Objective
We report here the results of an investigation to elucidate perception and knowledge on Mpox in an at-risk-population. In addition, we assessed how having received information from healthcare personnel may influence the knowledge of Mpox and willingness to undergo vaccination.
Materials and Methods
This is a cross-sectional observational study conducted between August and October 2022 and based on a self-administered anonymous questionnaire drafted by the Department of Infectious and Tropical Diseases of the ASST Spedali Civili of Brescia, Italy.
Population
Our study population is constituted by persons presenting to the sexually transmitted infection (STI) outpatient clinic of the Infectious Diseases Unit of the ASST Spedali Civili in Brescia. The patient cohort attending this clinic is predominantly composed of PLWH or HIV-seronegative patients with STIs, such as syphilis, gonorrhoea and chlamydia, therefore considered an at-risk population group for contracting Mpox.
Data Collection
A paper-based questionnaire was prepared by physicians of the unit of Infectious Diseases with the support of a clinical psychologist. The questionnaire was distributed to patients prior to their scheduled medical consultation. The self-administered anonymous questionnaire consisted of 29 multiple choice questions, which covered the following main topics: demographic information (Gender, Age, Nationality, Education, Level, Occupation); awareness and knowledge (16), fear and stigma (6) and vaccination acceptance (1).
Analysis
We performed a descriptive analysis describing frequencies of categorical variables. Fisher’s exact test was used to compare outcomes (awareness of Mpox as a dangerous disease, knowledge of preventive measures and willingness to undergo vaccination) between participants who have received specific information from health personnel; differences were considered significant when p < 0.05 (Epi Info 7.2 software).
Results
Characteristics of the Population
All individuals who were invited to participate in the study accepted and completed the questionnaire, with a response rate of 100%. Overall, 144 questionnaires were collected. The vast majority of the participants were of Italian nationality, (130;90%), of male gender (139;96.5%), and between 30 and 60 years of age (118;82%). Foreigners were mainly from South America (10;71.4%). For the majority (65;45.1%), the highest educational attainment was a high school diploma, while 34 (23.6%) participants held a bachelor’s degree. The vast majority were employed (121;84%), with the remaining individuals being either unemployed, retired, or still students.
Perception and Awareness
Almost all participants (136;94%) reported having heard about Mpox before, and more than half (80;56%) had received information about transmission. The information was perceived as complete by 14 respondents (10%). The main source of information was television and newspapers (118;82%), followed by the websites and social media (71;49%), healthcare professionals (24;16%) and finally word-of-mouth (14;10%).
Anzeige
The vast majority of participants (109;76%) believed that Mpox is a dangerous disease, mainly because it is an infectious disease (93;65%) and because it causes visible symptoms (28;19%), while few thought that it is incurable (7;5%). In fact, the majority (93;65%) think that there is a specific drug to cure Mpox. A third (45;31%) thought it is easy to acquire the infection, while half (76;53%) were unaware.
The majority of the cohort knew that transmission occurs through direct contact with an affected person (100;69%), and half also stated through sexual route (75;52%). The transmission route via respiratory droplets (20;14%), kissing (20;14%) and through objects (19;13%) and contaminated surfaces (2;1%) was the least selected.
Nearly half (59;41%) of respondents affirmed they thought they were at risk of getting the infection, and the majority (89;62%) were afraid to get it, mainly out of fear of a disease that is still little known, and out of social stigma and fear that the signs of infection may be visible.
The majority of participants (91; 63.2%) believe that friends and family members would react with negative emotions if they were to discover that they suffer from Mpox.
Anzeige
Despite the fear of the infection, the majority of participants (81;56%) responded that they did not increase the precautions they took for fear of Mpox. Indeed, most respondents (86;59.7%) declared they did not know what preventive measures to take to reduce the risk of infection.
Furthermore, less than half (61;42%) answered that using condoms could reduce the risk of infection, and the great majority (123;85%) do not think that hand washing is a proper Mpox prevention rule.
When asked if they would accept a vaccine to prevent the disease, more than a third (46;32%) of respondents expressed hesitation or complete refusal to be vaccinated. All these results are summarized in Table 1.
Table 1
Responses of participants to the questionnaire. Percentages are calculated on total participants
Demographics | N (%) |
|---|---|
Sex | |
Male | 139 (96.5%) |
Female | 4 (2.8%) |
Other | 1 (0.7%) |
Age | |
30–60 years of age | 118 (81.9%) |
> 60 years of age | 17 (11.8%) |
Nationality | |
Italian | 130 (90.3%) |
Foreign born | 14 (9.7%) |
Of which, from South America | 10 (71.4%) |
Education | |
Secondary school | 41 (28.5%) |
High school | 65 (45.1%) |
Degree | 34 (23.6%) |
Occupation | |
Employed | 121 (84%) |
Unemployed | 9 (6.3%) |
Retired | 11 (7.7%) |
Student | 3 (2%) |
Monkeypox perception and knowledge | |
Have you ever heard about monkeypox? | |
Yes | 136 (94.4%) |
No | 8 (5.6%) |
Have you ever received information about the transmission? | |
Yes | 80 (55.6%) |
No | 63 (43.8%) |
What was the source? (Multiple answer) | |
Health-care personnel/setting | 24 (16%) |
Web and social media | 71 (49.3%) |
Television and Newspapers | 118 (81.9%) |
Word-of-mouth | 14 (9.7%) |
The information received were (Multiple answer) | |
Completed | 14 (9.7%) |
Sufficient | 58 (40.3%) |
Insufficient | 43 (29.9%) |
Comprehensible | 21 (14.6%) |
Incomprehensible | 11 (7.7%) |
Do you think monkeypox is a dangerous disease? | |
Yes | 109 (75.7%) |
No | 32 (22.2%) |
Why do you thing is a dangerous disease? (Multiple answer) | |
It is an infectious disease | 93 (64.6%) |
It is incurable | 7 (4.9%) |
It is sexually transmitted | 29 (20.1%) |
It causes visible symptoms | 28 (19.4%) |
Do you think it is pharmaceutically treatable? | |
Yes | 93 (64.6%) |
No | 6 (4.1%) |
I don’t know | 44 (30.6%) |
In your opinion, is it easy to catch monkeypox? | |
Yes | 45 (31.3%) |
No | 22 (15.3%) |
I don’t know | 76 (52.7%) |
How is monkeypox transmitted? (Multiple answer) | |
By contact with infected persons | 100 (69.4%) |
By respiratory droplets | 20 (13.8%) |
By using contaminated items | 19 (13.2%) |
By contaminated surfaces | 2 (1.4%) |
By kissing | 20 (13.8%) |
By sex | 75 (52%) |
Do you know what preventive measures should be taken? | |
Yes | 55 (38.2%) |
No | 86 (59.7%) |
How do you think it is possible to reduce the risk of monkeypox transmission? (Multiple answer) | |
In no way | 7 (4.9%) |
Always using a condom | 61 (42.4%) |
Frequently washing hands | 21 (14.6%) |
Wearing a mask in public places | 16 (11.1%) |
Having only one sexual partner | 38 (26.4%) |
Avoiding casual sexual encounters | 47 (32.6%) |
Not exchanging personal items | 20 (13.9%) |
Do you usually take precautions against STIs? | |
Habitually | 112 (77.8%) |
Sometimes/rarely | 20 (13.9%) |
No, never | 4 (2.8%) |
Since the emergence of monkeypox, are you taking more precautions? | |
Yes | 54 (37.5%) |
No | 81 (56.3%) |
Are you afraid of being affected? | |
Yes | 89 (61.8%) |
No | 30 (20.8%) |
I don’t know | 18 (12.5%) |
Have you ever thought you were at risk of getting monkeypox? | |
Yes | 59 (41%) |
No | 76 (52.8%) |
How do you think family and friends would react if they knew you were affected by monkeypox? (Multiple answer) | |
Negatively (they would isolate me, judge me) | 91 (63.2%) |
They would support and help me | 31 (21.5%) |
No reaction | 35 (24.1%) |
If a vaccine was available, would you get it? | |
As soon as possible | 86 (59.7%) |
I would wait some time to see the effect on the people who did it | 40 (27.8%) |
I would never do that | 6 (4.2%) |
Anzeige
Significant differences were found in responses between participants who received medical information from health professionals and those who did not. The vast majority of those who received information from health professionals knew the preventive measures to be taken to avoid infection (15;62% vs. 40;36%, p = 0.022). Moreover, the first group declared that since the emergence of Mpox virus they had been taking more precautions against sexually transmitted infections (14;63% vs. 38; 35%, p = 0.017). However, we didn’t find significant differences on the acceptance or refusal of vaccinations between patients who received information about Mpox from healthcare professionals and those who did not (16;72% vs. 70; 66%, p = 062), as well the awareness of the danger of the disease (19;82% vs. 85;75%, p = 0.593). These results are represented in Table 2.
Table 2
Differences between answers in participants who acquired information from healthcare professionals and participants that got information elsewhere. Significance is established at p < 0.05
Monkeypox perception and knowledge | N (%) | p-value |
|---|---|---|
Monkeypox is a dangerous disease | ||
Healthcare personnel as source of information | 19 (82%) | p = 0.593 |
Others | 85 (75%) | |
Knowledge of the preventive measures | ||
Healthcare personnel as source of information | 15 (62%) | P = 0.022* |
Others | 40 (36%) | |
Taking more precautions against IST since the emergence of Mpox virus | ||
Healthcare personnel as source of information | 14 (63%) | P = 0.017* |
Others | 38 (35%) | |
If the smallpox vaccine becomes available, I would like to receive it as soon as possible | ||
Healthcare personnel as source of information | 16 (72%) | P = 0.624 |
Others | 70 (66%) | |
Discussion
The results of this study highlight a concerning lack of knowledge and awareness about Monkeypox among a cohort of individuals followed by an STI clinic, mostly composed of HIV-positive MSM, who are considered a population at risk for acquiring the infection. According to available literature, despite the use of multiple scales to assess the level of knowledge about Mpox in various studies, the results have generally indicated a poor or moderate level of knowledge [9], even among healthcare professionals and university students [7]. However, surveys on knowledge and awareness on Mpox targeting “at risk” communities are still scarce.
Despite the perceived severity of Mpox, a significant proportion of respondents did not increase the precautions they took to avoid infection and were unsure of the preventive measures to be taken. This lack of awareness and knowledge may contribute to a higher risk of infection, particularly given that more than a third of respondents expressed hesitation or refusal to accept a vaccine to prevent the disease. This data is concerning as it highlights that a significant portion of the population still requires awareness on the importance of vaccination. This data is in line with a survey in which only nearly half of MSM living with HIV in China were willing to get the Mpox vaccine [10]. The fact that no significant differences were found between patients who received information about Mpox from healthcare professionals and those who did not suggests that current efforts to disseminate information and promote vaccination may not be sufficient and that additional strategies are needed to increase vaccine uptake and improve knowledge about Mpox. A systematic review and meta-analysis have revealed that the general population had a low acceptance rate of Mpox vaccines (43%), whereas the acceptance rate was higher among the lesbian, gay, bisexual, and transgender (LGBTI) population (84%). As such, efforts should be made to prioritise education and promotion about Mpox, including transmission and preventive practices, within LGBTI communities, while stigma should be avoided [11].
While the majority of participants to our survey reported having heard about Mpox before, only a small percentage claimed to have received information about Mpox from healthcare professionals, and many did not believe the information they received was complete. Most of our respondents declared having received most information from traditional and modern social media. Two studies conducted in 2022, highlight the fundamental role that social media have gained in the last years in the spread of medical information, but also misinformation. In particular, he emphasised the tendency of the general population to retrieve information on Mpox on websites such as YouTube and Tik Tok, and almost never from channels led by healthcare professionals [12, 13]. This trend favours the spread of misleading and sometimes conspiratory theories, at the expense of attempts to improve communication between the scientific community and patients.
In fact, our study found that respondents who had received information from healthcare professionals had better knowledge about transmission and preventive measures and were more likely to take more precautions against sexually transmitted infections since the emergence of Mpox virus. This highlights the importance of healthcare professionals in providing accurate and complete information about Mpox and the need for increased tailored awareness-raising campaigns to target at-risk populations. Admitting the importance of social media in gaining attention from the general public could also be seen as an opportunity by the medical community to gain the trust of the population and spread useful information on current and future topics.
Conclusions
In conclusion, this study emphasises the critical importance of improving education and awareness strategies related to Mpox among high-risk populations. To achieve this goal, public health campaigns and healthcare providers must play a crucial role in disseminating accurate information and advocating for preventative measures aimed at mitigating the transmission risk of Mpox and other potential public health threats. To this end, the implementation of targeted health promotion and education strategies that facilitate resources for reducing high-risk behaviours and enhancing connections with healthcare professionals is of paramount importance. Such strategies should aim to empower individuals with the knowledge and resources necessary to make informed decisions about their health and wellbeing.
Acknowledgements
This work was accepted as poster at CISTM18.
Declarations
Conflict of interest
The Authors declare that they have no conflicts of interest regarding the topics discussed in this manuscript. *The authors are responsible for the choice and presentation of views contained in this article and for opinions expressed therein, which are not necessarily those of UNESCO and do not commit the Organizations.
Ethics approval and consent to participate
This study was conducted according to the guidelines of the Declaration of Helsinki.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.